Findings on Using Azilect (Rasagiline) as an Add-On Therapy

A Phase 3 Japanese trial has found that adding Azilect (rasagiline) to levodopa is safe, and over the course of a year improved motor function in those with Parkinson’s disease with off periods. The Journal of Neural Transmission published the results of the study Long-Term Safety and Efficacy of Adjunctive Rasagiline in Levodopa-Treated Japanese Patients with Parkinson’s Disease

Read More:

Add-on Azilect Safe and Effective in Levodopa-treated PD Patients, Phase 3 Trial in Japan Shows

Follow Us Follow us on TwitterFollow us on FacebookInstagram

Sign Up for Email Alerts

By providing your email you agree to receive periodic emails from The Parkinson Alliance.

Please tell us more about yourself:

This month is? (Anti-Spam)

Contact UsTerms Of UsePrivacy Policy

The Parkinson Alliance is a nonprofit, tax-exempt charitable organization under section 501(c)(3) of the Internal Revenue Code. Donations are tax-deductible as allowed by law. Copyright © 2020 The Parkinson Alliance. All rights reserved.